During the forecast period, the radioimmunoassay market is expected to grow at a CAGR of 4.10% on average. In 2022, the market is currently valued at US$ 448.03 million. The radioimmunoassay market is expected to reach a high of US$ 669.60 million by the year 2032. The analysis conducted by Future Market Insights revealed a historical market valuation of US$ 430.38 million.
With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis on radioimmunoassay market. FMI offers insights into the market data on over 5000+ drugs for more than 100 countries, which further aids the research on current and upcoming market scenario for the radioimmunoassay market. Our expert researchers and analysts for healthcare tracks the data of established players as well as new entrants in medical industry to provide an unbiased analysis for a sound and financial decision.
Over the past decade, healthcare sector has been expanding remarkably, following the advent of artificial Intelligence and the Internet of Things integrated medical devices. Advancement in technology has created impressive scope within the medical sector for diagnostics and therapeutics.
The report offers extensive data sets validating key trends impacting growth in the radioimmunoassay market. It offers insights into strategies adopted by the key players rise and address the concerns that will challenge the growth of radioimmunoassay market. With our extensive research and information about the past, current and future market scenario, the radioimmunoassay market report will help and identify the concerns, for a smooth-sail of the small & medium as well as large enterprises.
Radioimmunoassay market: Segmentation
- Kits and reagents
- Scientific research
- Medical diagnosis
By end user:
- Pharmaceutical and biotechnology industry
- Academic research institute
- Contract research organizations
Comprehensive analysis of the regional markets offers exclusive insights on the market performance across geographies along with relevant graphs, figures, and list of tables.
By prominent market players
DIAsource ImmunoAssays, Beckman Coulter, Inc., IBL Internationa, PerkinElmer, Inc, DRG International, Inc., MP Biomedicals, LLC, Cisbi, Euro Diagnostica AB, DiaSorin S.p.A., EMD Millipore, Izotop, Berthold Technologies GmbH.
With an extensive SWOT analysis, the FMI’s study presents the strengths, weaknesses, growth prospects and challenges of each player. The report also includes important data including the sales strategy, pricing strategy, and marketing strategy adopted by these players in the radioimmunoassay market. Future Market Insights